Wanbury (WANBURY) Share Price Falls 8.89%: Key Levels, Valuation and Peer Context
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Wanbury Share Price fell in today’s trade, with Wanbury last traded at Rs 197.85, down 8.89% from the previous close of Rs 217.15. The company’s market capitalisation stood at Rs 776.09 crore, placing it in the Micro Cap category. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move is notable because the stock opened near the day’s high, moved through a wide intraday band and then traded well below the previous close. For readers tracking Wanbury Share Price Today, the market is weighing a sharp decline against a set of strong reported profitability ratios and a valuation that sits below the wider industry averages. This Wanbury Share News update focuses on the verified price action, the current ratios and the sector backdrop rather than speculation.
For investors scanning Wanbury Stock News, the key question is not just why Wanbury Share Price slipped, but how today’s trade fits into the company’s broader fundamentals and healthcare sector comparison. Univest data shows the stock’s current price, valuation multiples, earnings metrics and peer positioning clearly enough to frame the move without adding an unsupported trigger. That makes Wanbury Share Price News useful for short-term monitoring as well as for a deeper fundamental analysis of where the stock stands inside the Pharmaceuticals & Drugs universe.
Wanbury (WANBURY) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 197.85 |
| Previous Close | Rs 217.15 |
| Today's Move | -Rs 19.30 (-8.89%) |
| Open | Rs 219.95 |
| High | Rs 219.95 |
| Low | Rs 195.5 |
| Market Capitalisation | Rs 776.09 crore |
| Market Cap Category | Micro Cap |
Wanbury Share Price Today shows a clear single-day decline. The stock traded at Rs 197.85 versus the previous close of Rs 217.15, marking a fall of Rs 19.30 or 8.89%. It opened at Rs 219.95, which was also the day high, and later touched a low of Rs 195.50. That range shows that the trade moved lower after the opening print and then remained near the lower end of the day’s band. For a Micro Cap company with a market cap of Rs 776.09 crore, such a move keeps Wanbury Share Price firmly in focus for active market watchers. According to latest Univest figures, the decline is confirmed, while the price structure alone does not establish a company-specific reason. For anyone following Wanbury Share Price Live, the immediate reference points remain the previous close, the opening level and the day low.
Wanbury Share Price also matters because the intraday path was not a narrow drift. The stock touched Rs 219.95 early, then weakened to Rs 195.50, leaving the final price close to the lower end of the range. That makes Wanbury Share Price Update relevant for traders and longer-term readers alike. The facts answer what happened today; the next question is whether the company’s financial ratios and industry context help explain how investors may read the move.
Wanbury (WANBURY) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 776.09 crore |
| P/E Ratio | 13.59x |
| P/B Ratio | 5.17x |
| ROE | 67.87% |
| ROCE | 30.31% |
| EPS | Rs 15.98 |
| Book Value Per Share | Rs 41.96 |
| Dividend Yield | 0% |
Wanbury (WANBURY) fundamental metrics show P/E 13.59x, P/B 5.17x, ROE 67.87%, ROCE 30.31%. These figures provide context only and are not a buy or sell signal.
Wanbury has a market capitalisation of Rs 776.09 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 13.59x, P/B at 5.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 67.87% and ROCE of 30.31%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.98, book value per share of Rs 41.96, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.43x, median ROE of 11.7%, median ROCE of 13.61%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 13.59x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 5.17x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 67.87% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 30.31% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 776.09 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Wanbury (WANBURY) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Wanbury (WANBURY) has a P/E ratio of 13.59x, which is below the benchmark median of 32.43x, a difference of -58.09%. On its own, the P/E gap is a valuation reference point, not a trading call.
Wanbury (WANBURY) has a ROE of 67.87%, which is above the benchmark median of 11.7%, a difference of +480.09%. Wanbury (WANBURY) has a ROCE of 30.31%, which is above the benchmark median of 13.61%, a difference of +122.7%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
Wanbury (WANBURY) has a P/E ratio of 13.59x compared with the displayed peer median of 36.9x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 67.87% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 30.31% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wanbury (WANBURY) has a market capitalisation of Rs 776.09 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Wanbury
- Wanbury Share Price fell 8.89% in one trade, so the price action itself is the first point to track.
- The stock moved from a high of Rs 219.95 to a low of Rs 195.50, which gives the day’s range useful context.
- Wanbury Share Price trades with a P/E of 13.59, below the industry median in the snapshot.
- The company reports ROE of 67.87% and ROCE of 30.31%, both above the sector benchmark averages.
- Wanbury Market Cap is Rs 776.09 crore, so the stock remains in the Micro Cap category and may move sharply on news.
About Wanbury
Wanbury operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s verified profile in this article is anchored by its market cap, valuation ratios and return measures rather than by any unsupported business claim. For readers looking at Wanbury Share Price alongside company context, the stock belongs to a pharmaceutical business that is evaluated through earnings, book value and return on capital. The verified numbers show that Wanbury Share Price is being assessed in a sector where peer scale is much larger, but the company still shows strong reported ROE and ROCE. That is the clearest company overview available from the figures being used here.
Track Wanbury Share Price on Univest
Use Wanbury (WANBURY) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Wanbury Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. For Wanbury Share Price Today, the most useful checks are the current price, previous close, market cap and valuation ratios. Univest also helps place Wanbury Stock News in the context of sector and peer comparison.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Wanbury Share Price falling today?
Ans. Wanbury Share Price fell 8.89% to Rs 197.85 in today’s trade. According to Univest data, the price event is confirmed, but no company-specific catalyst is established from the verified figures.
What is Wanbury Share Price today?
Ans. Wanbury Share Price Today stood at Rs 197.85, compared with the previous close of Rs 217.15. The move reflects a drop of Rs 19.30 in the current trade session. The stock moved 8.89% lower during the session.
What is the market cap of Wanbury?
Ans. Wanbury’s market capitalisation is Rs 776.09 crore, which places it in the Micro Cap category. That size context is important when reading Wanbury Share Price moves and comparing it with larger pharma peers.
What is Wanbury’s P/E ratio?
Ans. Wanbury’s P/E ratio is 13.59. In the sector snapshot, that sits below the industry median of 32.43 and below the average of 49.46 for the same industry benchmark. Its P/B ratio is 5.17x.
How does Wanbury compare with pharma peers?
Ans. Wanbury Share Price is supported by a lower P/E than Sun Pharma, Divi’s Laboratories, Torrent Pharma, Zydus Lifesciences and Cipla in the peer set. Its market cap is also much smaller than those listed comparables.
What do Wanbury’s ROE and ROCE show?
Ans. Wanbury reports ROE of 67.87% and ROCE of 30.31%. Both figures are higher than the benchmark medians and averages in the sector snapshot, which gives Wanbury Share Price important fundamental context.
Should investors track Wanbury Share Price now?
Ans. Investors tracking Wanbury Share Price may focus on the day’s decline, the Micro Cap category, the P/E of 13.59 and the strong reported ROE and ROCE. Univest will keep the share price and stock context updated.
